Aspects of the interaction between cisplatin and renal glutathione

Aspects of the interaction between cisplatin and renal glutathione

Bibliographic Details
Main Author:	Merazga, Yamina
Published:	Brunel University 1990
Subjects:	572 Cancer chemotherapy
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.235899

Similar Items

The interaction of mithramycin with DNA
by: Cons, Benjamin Major George
Published: (1990)

Design and synthesis of fluorodeoxyuridine derivatives and their conjunction with monoclonal antibody for the purpose of drug targeting
by: Henn, Thomas Frederic George
Published: (1990)

Mechanisms of enhancement of antimetabolite cytotoxicity by 3-aminobenzamide
by: Willmore, Elaine
Published: (1994)

Interaction between glutathione S‐transferase M1‐null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer
by: Shuang Li, et al.
Published: (2018-09-01)

Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin
by: Khynriam D., et al.
Published: (2003-01-01)

Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
by: Nguyen, Jenny
Published: (2010)

Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
by: Nguyen, Jenny
Published: (2010)

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
by: Hikmat Abdel-Razeq, et al.
Published: (2018-03-01)

Domain and subunit interactions and the catalytic mechanism of glutathione reductase
by: Walentas, Christopher David
Published: (1998)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
by: Minghui Liu, et al.
Published: (2021-03-01)

Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer
by: Joerg Herrmann, MD
Published: (2020-09-01)

Azoreductases in cancer therapy
by: Sims, Margaret Alison
Published: (1994)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
by: Muhammad Furqan, et al.
Published: (2019-06-01)

The identification of 14-3-3 [sigma] as a contributor to cisplatin resistance in esophageal squamous cell carcinoma
by: Lai, King-yin, et al.
Published: (2015)

Cisplatin and Paclitaxel Modulated the Cell Survival Potential of Prostate Cancer Cells
by: Sina Kashani, et al.
Published: (2020-01-01)

Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial
by: Yuichiro Hayashi, et al.
Published: (2018-07-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

The efficacy of strategies used to minimise or prevent Cisplatin-induced ototoxicity in patients
by: Zenzo S. Chakara, et al.
Published: (2019-01-01)

Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
by: Mayr Martina, et al.
Published: (2012-12-01)

Somatic genetic analysis of p53 function and cisplatin resistance
by: Gallagher, William
Published: (1996)

Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo
by: Kensaku Abe, et al.
Published: (2019-07-01)

The Interaction of Human Glutathione Transferase GSTA1-1 with Reactive Dyes
by: Mohammed Hamed Alqarni, et al.
Published: (2021-04-01)

Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01)

EFFECT OF CHEMOTHERAPY WITH DOCETAXEL / CISPLATIN ON GRANULOCYTIC HEMOPOIESIS IN PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA
by: V. E. Goldberg, et al.
Published: (2016-11-01)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
by: Frédéric Fiteni, et al.
Published: (2016-11-01)

Effect of preoperative paclitaxel + cisplatin neoadjuvant chemotherapy on the proliferation and invasion of cancer cells in esophageal cancer
by: Cong-Hua Chen
Published: (2018-04-01)

Studies on human nucleoside phosphorylase
by: Marr, Clara Lok-Po
Published: (1992)

Penicillin-binding protein 2' of methicillin-resistant Staphylococcus aureus : purification and immunological detection
by: O'Hara, Denise Mary
Published: (1988)

Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)
by: Keijiro Sugimura, et al.
Published: (2021-01-01)

Pharmacogenetics of Extraordinary Responses to 5-FU/Cisplatin Chemotherapy in Advanced Gastric Cancer – Report of 2 Cases
by: Wolschke, Christine, et al.
Published: (2014)

THE CLINICAL AND HISTOPATHOLOGICAL EFFECTS OF COMBINED CHEMOTHERAPY USING CISPLATIN AND PEPLOMYCIN TO TREAT CANCER OF THE TONGUE
by: UEDA, MINORU, et al.
Published: (1995)

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
by: Ma Qingshan, et al.
Published: (2012-11-01)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
by: Meysam Moghbeli
Published: (2021-09-01)

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
by: Glenn F. Van Wigcheren, et al.
Published: (2021-01-01)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01)

Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01)

Effect of paclitaxel + cisplatin chemotherapy before radical operation for esophageal cancer on the malignant degree of tumor
by: Wei Chen
Published: (2018-10-01)

Relationship between the Expression of the Thymidylate Synthase and the Prognosis of Gastric Cancer Patients Treated with Combinational Chemotherapy Regimen Including Fluorouracil, Docetaxel and Cisplatin
by: Mozaffar Aznab, et al.
Published: (2020-07-01)

Posssible enhancement of long-term fear conditioning performance by cisplatin administration in rats
by: Bruno Kilpp Goulart, et al.
Published: (2012-01-01)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial
by: Michele De Simone, et al.
Published: (2020-04-01)